/

Empresas

Pe

No verificado

Perfuze

Sobre qué escribimos

3 Comunicados de prensa

Ver todos los comunicados de prensa

16/07/2025

Perfuze Presents Preliminary Results from MARRS Pivotal Trial at SNIS, Highlighting Millipede88 Performance in Acute Ischemic Stroke

Fuente

Editor

1.00

0

22/04/2025

Perfuze Announces Completion of Enrollment in Pivotal US Clinical Study and Appointment of Joe Rotger as Executive Vice President of Sales

Fuente

Editor

1.00

0

13/03/2025

Perfuze Receives FDA 510(k) Clearance for Zipline™ Access Catheters and Secures €22M in Additional Funding

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0